Corgenix Medical Corporation

Broomfield, CO 80020

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $2.59MM
First Award Date 04/01/10
Most Recent Award Date 06/01/15

Key Personnel

Last Name Name Awards Contact
Lopez Luis R. Lopez 2
PITTS KELLY R PITTS 2

4 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 06/01/15 - 05/31/16

DESCRIPTION (provided by applicant): The proposed project will further develop marketable ELISA and lateral-flow immunoassay diagnostics (LFI) in both monoplexed and multiplexed formats for the NIAID category A, BSL-4 filoviruses, and will drive pre-clinical development and validation for these diagnostics. These assays will be used for diagnosi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 06/15/14 - 05/31/15

DESCRIPTION (provided by applicant): The proposed project will further develop marketable ELISA and lateral-flow immunoassay diagnostics (LFI) in both monoplexed and multiplexed formats for the NIAID category A, BSL-4 filoviruses, and will drive pre-clinical development and validation for these diagnostics. These assays will be used for diagnosi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 04/01/11 - 09/30/12

DESCRIPTION (provided by applicant): Viral hemorrhagic fevers (VHFs) are serious, often fatal, illnesses characterized by high fever, damage to the vascular system and multiorgan failure. Our team has successfully produced prototype Lassa virus ELISA that are based on recombinant proteins rather than on reagents that must be produced in high con...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 04/01/10 - 03/31/11

DESCRIPTION (provided by applicant): Viral hemorrhagic fevers (VHFs) are serious, often fatal, illnesses characterized by high fever, damage to the vascular system and multiorgan failure. Our team has successfully produced prototype Lassa virus ELISA that are based on recombinant proteins rather than on reagents that must be produced in high con...